Results 231 to 240 of about 31,662 (260)

SMC4 Promotes Prostate Cancer Cell Proliferation and Metastasis via the Rheb/mTOR Pathway. [PDF]

Adv Sci (Weinh)
Zhang W, Qin S, Li X, Chang M, Wei T, Huang X, Tong H, Guo X, Lu Y, Zhang J.   +9 more
europepmc   +1 more source

TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. [PDF]

Int J Biol Sci
Yin Y, Sun Y, Yao H, Yu F, Jia Q, Hu C, Zhu Y, Duan Z, Liu D, Sun Y, Huo Y, Yang M, Liu W.   +12 more
europepmc   +1 more source

Glucose transporter 2‑transported glucosamine inhibits glycolysis in cancer cell lines through competition with glucose for hexokinase II. [PDF]

Oncol Rep
Park SY, Song KH, Kang JH, Oh SH.
europepmc   +1 more source

La dolce vita: fueling chimeric antigen receptor (CAR) T cells with Glut1 to improve therapeutic efficacy. [PDF]

Immunometabolism (Cobham)
Slattery K, Finlay DK, Darcy PK.
europepmc   +1 more source

Immune-metabolic crosstalk in HNSCC: mechanisms and therapeutic opportunities. [PDF]

Front Oncol
Qin X, Wu H, Pan J, Kang K, Shi Y, Bu S.
europepmc   +1 more source

Bidirectional modulation of glycolysis using a multifunctional nanocomposite hydrogel promotes bone fracture healing in type 2 diabetes mellitus. [PDF]

Bioact Mater
Zhang S, Hu W, Zhao Y, Liao Y, Zha K, Zhang W, Yu C, Liao J, Li H, Zhou W, Cao F, Mi B, Liu G.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Role for GLUT1 in diabetic glomerulosclerosis

Expert Reviews in Molecular Medicine, 2006
Numerous studies have investigated specific pathways that link diabetes and high extracellular glucose exposure to glomerulosclerosis and mesangial cell extracellular matrix production. However, only in the past ten years has a role for glucose transporters in this process been addressed.
Frank C. Brosius, Charles W. Heilig, Carol C. Cunningham   +2 more
openaire   +2 more sources

GLUT1 deficiency syndrome: An update

Revue Neurologique, 2014
Glucose transporter type 1 deficiency syndrome is caused by heterozygous, mostly de novo, mutations in the SLC2A1 gene encoding the glucose transporter GLUT1. Mutations in this gene limit brain glucose availability and lead to cerebral energy deficiency.The phenotype is characterized by the variable association of mental retardation, acquired ...
Emmanuel Roze, S. Caillet, D. Gras, Fanny Mochel, Diane Doummar, T. Billette de Villemeur, Marie Vidailhet, Aurélie Méneret   +7 more
openaire   +3 more sources